Rchr
J-GLOBAL ID：200901008670423041
Update date: Oct. 01, 2022
Sakamoto Yasuo
サカモト ヤスオ | Sakamoto Yasuo
Affiliation and department：
Kumamoto University Graduate School of Medical Sciences
About Kumamoto University Graduate School of Medical Sciences
Search "Kumamoto University Graduate School of Medical Sciences"
Detailed information
Papers (111)：
Ryuma Tokunaga, Yasuo Sakamoto, Shigeki Nakagawa, Daisuke Izumi, Keisuke Kosumi, Katsunobu Taki, Takaaki Higashi, Tatsunori Miyata, Yuji Miyamoto, Naoya Yoshida, et al. Comparison of systemic inflammatory and nutritional scores in colorectal cancer patients who underwent potentially curative resection. International journal of clinical oncology. 2017. 22. 4. 740-748
Kenichi Nakamura, Naoya Yoshida, Yoshifumi Baba, Keisuke Kosumi, Tomoyuki Uchihara, Yuki Kiyozumi, Mayuko Ohuchi, Takatsugu Ishimoto, Masaaki Iwatsuki, Yasuo Sakamoto, et al. Elevated preoperative neutrophil-to-lymphocytes ratio predicts poor prognosis after esophagectomy in T1 esophageal cancer. International journal of clinical oncology. 2017. 22. 3. 469-475
Ryuma Tokunaga, Yasuo Sakamoto, Shigeki Nakagawa, Naoya Yoshida, Hideo Baba. The utility of tumor marker combination, including serum P53 antibody, in colorectal cancer treatment. SURGERY TODAY. 2017. 47. 5. 636-642
Naoya Yoshida, Kazuto Harada, Yoshifumi Baba, Keisuke Kosumi, Masaaki Iwatsuki, Koichi Kinoshita, Kenichi Nakamura, Yasuo Sakamoto, Yuji Miyamoto, Ryuichi Karashima, et al. Preoperative controlling nutritional status (CONUT) is useful to estimate the prognosis after esophagectomy for esophageal cancer. Langenbeck's archives of surgery. 2017. 402. 2. 333-341
Yukiharu Hiyoshi, Naoya Yoshida, Masayuki Watanabe, Junji Kurashige, Yoshifumi Baba, Yasuo Sakamoto, Hideo Baba. The Presence of Serum p53 Antibody Predicts the Pathological Tumor Response to Neoadjuvant Chemotherapy with Docetaxel, Cisplatin and Fluorouracil (DCF) in Esophageal Squamous Cell Carcinoma. WORLD JOURNAL OF SURGERY. 2017. 41. 2. 480-486
ｍore...
Lectures and oral presentations (102)：
消化器癌におけるLINE-1メチル化レベルの予後予測および効果予測バイオマーカーとしての意義
(第13回日本消化管学会総会学術集会 2017)
腹腔鏡下前方切除術における縫合不全予防のための工夫
(第86回大腸癌研究会 2017)
胃癌患者治療前のSTNとCEAの測定意義
(第89回日本胃癌学会総会 2016)
The impact of RHOA mutation related with invasion in diffuse-type gastric cancer
(第89回日本胃癌学会総会 2016)
Prognostic accuracy of preoperative PNI and mGPS in gastric cancer patients with curative resection
(第89回日本胃癌学会総会 2016)
ｍore...
Works (2)：
ヒストン脱メチル化酵素を制御するmicroRNAを標的とした新規治療法の開発
坂本快郎 2015 - 2017
内臓肥満が大腸癌の予後に与える影響とそのメカニズムの解析
坂本快郎 2014 - 2016
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in
researchmap
.
For details, see here
.
Return to Previous Page
TOP
BOTTOM
